WorldQuant Millennium Advisors’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Sell
16,163
-186,257
-92% -$5.5M ﹤0.01% 644
2026
Q1
$5.61M Buy
202,420
+126,259
+166% +$3.24M 0.02% 328
2025
Q4
$1.65M Sell
76,161
-253,774
-77% -$5.01M 0.01% 436
2025
Q3
$4.99M Buy
+329,935
New +$4.08M 0.02% 294

Other funds holding ROIV

WorldQuant Millennium Advisors's ROIV Position: Q2 2026 in Review

WorldQuant Millennium Advisors reduced its Roivant Sciences (ROIV) stake by 92% in Q2 2026, selling an estimated $5.5M and leaving 16,163 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

WorldQuant Millennium Advisors first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.61M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • WorldQuant Millennium Advisors held 16,163 shares of Roivant Sciences worth $572K as of Q2 2026.
  • WorldQuant Millennium Advisors sold 186,257 Roivant Sciences shares in Q2 2026, an estimated $5.5M.
  • Roivant Sciences made up ﹤0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #644 holding.
  • WorldQuant Millennium Advisors first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • WorldQuant Millennium Advisors's Roivant Sciences position peaked at $5.61M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.